768 related articles for article (PubMed ID: 30140973)
1. Crosstalk Between Inflammation and Glutamate System in Depression: Signaling Pathway and Molecular Biomarkers for Ketamine's Antidepressant Effect.
Cui W; Ning Y; Hong W; Wang J; Liu Z; Li MD
Mol Neurobiol; 2019 May; 56(5):3484-3500. PubMed ID: 30140973
[TBL] [Abstract][Full Text] [Related]
2. Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review.
du Jardin KG; Müller HK; Elfving B; Dale E; Wegener G; Sanchez C
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():27-38. PubMed ID: 27262695
[TBL] [Abstract][Full Text] [Related]
3. What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities.
Strasburger SE; Bhimani PM; Kaabe JH; Krysiak JT; Nanchanatt DL; Nguyen TN; Pough KA; Prince TA; Ramsey NS; Savsani KH; Scandlen L; Cavaretta MJ; Raffa RB
J Clin Pharm Ther; 2017 Apr; 42(2):147-154. PubMed ID: 28111761
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant Effect of Ketamine on Inflammation-Mediated Cytokine Dysregulation in Adults with Treatment-Resistant Depression: Rapid Systematic Review.
Sukhram SD; Yilmaz G; Gu J
Oxid Med Cell Longev; 2022; 2022():1061274. PubMed ID: 36160713
[TBL] [Abstract][Full Text] [Related]
5. Inflammation, stress and depression: An exploration of ketamine's therapeutic profile.
Johnston JN; Greenwald MS; Henter ID; Kraus C; Mkrtchian A; Clark NG; Park LT; Gold P; Zarate CA; Kadriu B
Drug Discov Today; 2023 Apr; 28(4):103518. PubMed ID: 36758932
[TBL] [Abstract][Full Text] [Related]
6. [Ketamine's antidepressant effect: focus on ketamine mechanisms of action].
De Maricourt P; Jay T; Goncalvès P; Lôo H; Gaillard R
Encephale; 2014 Feb; 40(1):48-55. PubMed ID: 24434007
[TBL] [Abstract][Full Text] [Related]
7. Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism.
Aleksandrova LR; Phillips AG; Wang YT
J Psychiatry Neurosci; 2017 Jun; 42(4):222-229. PubMed ID: 28234212
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers of ketamine's antidepressant effect: An umbrella review.
Meshkat S; Ho RC; Cao B; Teopiz KM; Rosenblat JD; Rhee TG; Di Vincenzo JD; Ceban F; Jawad MY; McIntyre RS
J Affect Disord; 2023 Feb; 323():598-606. PubMed ID: 36521662
[TBL] [Abstract][Full Text] [Related]
9. Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition.
Miller OH; Moran JT; Hall BJ
Neuropharmacology; 2016 Jan; 100():17-26. PubMed ID: 26211972
[TBL] [Abstract][Full Text] [Related]
10. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
[TBL] [Abstract][Full Text] [Related]
11. Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.
Kokane SS; Armant RJ; Bolaños-Guzmán CA; Perrotti LI
Behav Brain Res; 2020 Apr; 384():112548. PubMed ID: 32061748
[TBL] [Abstract][Full Text] [Related]
12. Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.
Niciu MJ; Henter ID; Luckenbaugh DA; Zarate CA; Charney DS
Annu Rev Pharmacol Toxicol; 2014; 54():119-39. PubMed ID: 24392693
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of ketamine action as an antidepressant.
Zanos P; Gould TD
Mol Psychiatry; 2018 Apr; 23(4):801-811. PubMed ID: 29532791
[TBL] [Abstract][Full Text] [Related]
14. Changes in neurotrophic signaling pathways in brain areas of the chronic mild stress rat model of depression as a signature of ketamine fast antidepressant response/non-response.
Derosa S; Misztak P; Mingardi J; Mazzini G; Müller HK; Musazzi L
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jan; 128():110871. PubMed ID: 37793481
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of neuregulin 1-ErbB4 signaling in parvalbumin interneurons in the rat brain may contribute to the antidepressant properties of ketamine.
Wang N; Zhang GF; Liu XY; Sun HL; Wang XM; Qiu LL; Yang C; Yang JJ
J Mol Neurosci; 2014; 54(2):211-8. PubMed ID: 24633675
[TBL] [Abstract][Full Text] [Related]
16. Translational control by ketamine and its implications for comorbid cognitive deficits in depressive disorders.
Lewis V; Rodrigue B; Arsenault E; Zhang M; Taghavi-Abkuh FF; Silva WCC; Myers M; Matta-Camacho E; Aguilar-Valles A
J Neurochem; 2023 Jul; 166(1):10-23. PubMed ID: 35680556
[TBL] [Abstract][Full Text] [Related]
17. Ketamine: The final frontier or another depressing end?
Sial OK; Parise EM; Parise LF; Gnecco T; Bolaños-Guzmán CA
Behav Brain Res; 2020 Apr; 383():112508. PubMed ID: 32017978
[TBL] [Abstract][Full Text] [Related]
18. Ketamine's rapid and sustained antidepressant effects are driven by distinct mechanisms.
Rawat R; Tunc-Ozcan E; Dunlop S; Tsai YH; Li F; Bertossi R; Peng CY; Kessler JA
Cell Mol Life Sci; 2024 Feb; 81(1):105. PubMed ID: 38413417
[TBL] [Abstract][Full Text] [Related]
19. Ketamine as a fast acting antidepressant: current knowledge and open questions.
Salvadore G; Singh JB
CNS Neurosci Ther; 2013 Jun; 19(6):428-36. PubMed ID: 23578128
[TBL] [Abstract][Full Text] [Related]
20. Ketamine's antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorder.
Niciu MJ; Luckenbaugh DA; Ionescu DF; Richards EM; Vande Voort JL; Ballard ED; Brutsche NE; Furey ML; Zarate CA
Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
